Kato Y - Search Results

1

Tear fluid and complement activation products in tears after ocular surgery.

Maehara H, Norikawa K, Tanaka K, Kato Y, Kasai A, Omori T, Machida T, Sekine H, Sekiryu T. Maehara H, et al. Among authors: kato y. BMC Ophthalmol. 2023 Jul 18;23(1):329. doi: 10.1186/s12886-023-03037-6. BMC Ophthalmol. 2023. PMID: 37464366 Free PMC article.

2

Evidence for Activation of Lectin and Classical Pathway Complement Components in Aqueous Humor of Neovascular Age-Related Macular Degeneration.

Omori T, Oguchi Y, Machida T, Kato Y, Ishida Y, Ojima A, Itagaki K, Shintake H, Tomita R, Kasai A, Sugano Y, Ogasawara M, Sekine H, Sekiryu T. Omori T, et al. Among authors: kato y. Ophthalmic Res. 2020;63(3):252-258. doi: 10.1159/000503258. Epub 2019 Oct 23. Ophthalmic Res. 2020. PMID: 31645047

3

Anaphylatoxin concentration in aqueous and vitreous humor in the eyes with vitreoretinal interface abnormalities.

Oguchi Y, Sekiryu T, Omori T, Kato Y, Ogasawara M, Sugano Y, Itagaki K, Ojima A, Machida T, Sekine H. Oguchi Y, et al. Among authors: kato y. Exp Eye Res. 2020 Jun;195:108025. doi: 10.1016/j.exer.2020.108025. Epub 2020 Mar 26. Exp Eye Res. 2020. PMID: 32224205 Review.

4

Complement Activation Products and Cytokines in Pachychoroid Neovasculopathy and Neovascular Age-Related Macular Degeneration.

Kato Y, Oguchi Y, Omori T, Shintake H, Tomita R, Kasai A, Ogasawara M, Sugano Y, Itagaki K, Ojima A, Machida T, Sekine H, Sekiryu T. Kato Y, et al. Invest Ophthalmol Vis Sci. 2020 Nov 2;61(13):39. doi: 10.1167/iovs.61.13.39. Invest Ophthalmol Vis Sci. 2020. PMID: 33252634 Free PMC article.

5

Morphometrics in three dimensional choroidal vessel models constructed from swept-source optical coherence tomography images.

Sugano Y, Maeda S, Kato Y, Kasai A, Tsuji S, Okamoto M, Sekiryu T. Sugano Y, et al. Among authors: kato y. Sci Rep. 2022 Sep 6;12(1):15130. doi: 10.1038/s41598-022-17039-9. Sci Rep. 2022. PMID: 36068250 Free PMC article.

6

Kato Y, Oguchi Y, Omori T, Kasai A, Ogasawara M, Sugano Y, Itagaki K, Ojima A, Ishida Y, Machida T, Sekine H, Sekiryu T. Kato Y, et al. Ophthalmol Sci. 2022 Apr 30;2(2):100167. doi: 10.1016/j.xops.2022.100167. eCollection 2022 Jun. Ophthalmol Sci. 2022. PMID: 36249678 Free PMC article.

7

MACULAR SENSITIVITY CHANGE AFTER COMPLEMENTARY LASER THERAPY AFTER RANIBIZUMAB INTRAVITREAL INJECTION IN BRANCH RETINAL VEIN OCCLUSION.

Ojima A, Kato Y, Tomita R, Kasai A, Sugano Y, Sekiryu T. Ojima A, et al. Among authors: kato y. Retina. 2023 Jun 1;43(6):999-1004. doi: 10.1097/IAE.0000000000003749. Retina. 2023. PMID: 36696603

8

Complement activation products in tears of dry eye and meibomian gland dysfunction.

Maehara H, Norikawa K, Tanaka K, Kato Y, Kasai A, Mukai R, Omori T, Machida T, Sekine H, Sekiryu T. Maehara H, et al. Among authors: kato y. Sci Rep. 2024 Jan 2;14(1):43. doi: 10.1038/s41598-023-46634-7. Sci Rep. 2024. PMID: 38168536 Free PMC article.

9

Intraocular pressure changes during intravitreal aflibercept injection based on treat-and-extend regimen in Japanese patients with neovascular age-related macular degeneration and glaucoma.

Honjo J, Mukai R, Itagaki K, Tanaka K, Norikawa K, Kato Y, Kasai A, Sugano Y, Sekiryu T. Honjo J, et al. Among authors: kato y. Jpn J Ophthalmol. 2024 Mar;68(2):91-95. doi: 10.1007/s10384-023-01041-3. Epub 2024 Feb 6. Jpn J Ophthalmol. 2024. PMID: 38316703

10

Development of a microvessel density gene signature and its application in precision medicine.

Kuronishi M, Ozawa Y, Kimura T, Li SD, Kato Y. Kuronishi M, et al. Among authors: kato y. Cancer Res Commun. 2025 Jan 21. doi: 10.1158/2767-9764.CRC-24-0403. Online ahead of print. Cancer Res Commun. 2025. PMID: 39835481

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,741 results

Search Page

Filters